The Hemp Clinic Clinical-minded CBD guidance for UK wellness.

The Hemp Clinic

Clinical-minded CBD guidance for UK wellness.

Latest Articles

Pollen, Pills and Precaution: Placing CBD Within a UK Hay Fever Season
Seasonal Wellness

Pollen, Pills and Precaution: Placing CBD Within a UK Hay Fever Season

Every spring the CBD shelf acquires a hay fever aisle it did not previously have. This seasonal reading separates the laboratory anti-inflammatory story from the human evidence, maps the interaction risks with common allergy medicines, and offers a practical checklist for the UK pollen calendar.

The Precautionary Pause: CBD, Pregnancy and the Unanswered Questions UK Clinicians Still Carry
Clinical Education

The Precautionary Pause: CBD, Pregnancy and the Unanswered Questions UK Clinicians Still Carry

Absence of evidence is routinely mistaken for evidence of safety, and nowhere is that confusion more consequential than in pregnancy. This briefing sets out why CBD is not recommended before, during or after pregnancy, what the evidence can and cannot support, and how the conversation with a midwife should be framed.

Inhaled, Not Inferred: A Clinical Reading of CBD E-Liquids for UK Adults in 2026
Consumer Guidance

Inhaled, Not Inferred: A Clinical Reading of CBD E-Liquids for UK Adults in 2026

Vaping is the fastest route a cannabinoid can take into the bloodstream, and the least documented. This briefing sets out what inhalation does pharmacologically, where UK regulation currently stops, and why a lower-tech dropper may still be the more defensible choice for most adults.

Clinical Education

Two Counters, One Molecule: Reading the UK’s Cannabinoid Divide in 2026

Prescribed cannabinoid medicines and high-street CBD wellness products occupy different legal, clinical and regulatory worlds in the UK. This briefing explains the distinction, who can access what, and the questions UK readers should ask before treating a shelf claim like a script.

Signals, Symptoms and the Supplement Shelf: A Clinical Briefing on CBD and IBS for UK Adults
Clinical Education

Signals, Symptoms and the Supplement Shelf: A Clinical Briefing on CBD and IBS for UK Adults

Irritable bowel syndrome is among the most common long-term complaints seen in UK general practice, and cannabidiol is increasingly mentioned in the same breath as bloating, urgency and cramping. This briefing sets out what the gut–brain axis hypothesis does and does not support, how over-the-counter CBD is actually regulated in the UK, and which symptoms should send a reader to a GP rather than to a retail website.

Slow Release, Uncertain Reach: A Clinical Reading of CBD Patches for UK Shoppers
Consumer Guidance

Slow Release, Uncertain Reach: A Clinical Reading of CBD Patches for UK Shoppers

CBD patches are marketed as a discreet, steady alternative to oils and capsules, but the gap between the claim and the measured evidence is wider than many UK shoppers realise. This appraisal examines transdermal delivery, wear-time instructions, labelling and regulatory positioning, and the practical cautions that matter for anyone using prescribed medicines.

Aura, Attack and Aftermath: Placing CBD Carefully Within UK Migraine Care
Clinical Education

Aura, Attack and Aftermath: Placing CBD Carefully Within UK Migraine Care

CBD is often discussed as though it were a single answer to migraine, but acute relief and prevention are separate clinical questions. This briefing sets out what UK sufferers should weigh, where the evidence is thin, and why diagnosis and red-flag awareness come before any dropper.

Clinical Education

The Balm Is Not the Barrier: A Clinical Appraisal of CBD Topicals for Eczema and Psoriasis in the UK

CBD balms and creams are often marketed with soothing language, but eczema and psoriasis are not simply dry-skin problems. This clinical appraisal sets out what UK shoppers can reasonably expect from topical CBD, how to read a formulation, and when NHS care should remain the anchor.

The Cyclical Question: Can CBD Earn a Place Beside Heat and Ibuprofen for UK Period Pain?
Clinical Education

The Cyclical Question: Can CBD Earn a Place Beside Heat and Ibuprofen for UK Period Pain?

Menstrual cramps are among the most commonly cited reasons UK shoppers give for trying CBD, yet the evidence base remains thin and largely indirect. This briefing separates what topical balms can reasonably offer from what swallowed CBD has yet to prove, examines the label and dosing traps specific to the UK market, and sets out the red-flag symptoms that should send a woman to her GP rather than to a shelf.

Desk, Cup and Cannabinoid: A 2026 Clinical Audit of CBD and Caffeine at Work
Clinical Education

Desk, Cup and Cannabinoid: A 2026 Clinical Audit of CBD and Caffeine at Work

Pairing CBD with tea, coffee or energy drinks is a common UK desk-day habit, but timing and dose deserve more attention than marketing suggests. This clinical audit sets out what office workers can reasonably track over two weeks, how to read caffeine and cannabinoid labels, and when to keep the two apart.

The Documented Dropper: CBD, Workplace Screening and the Calm Conversation With Your Employer in 2026
Consumer Guidance

The Documented Dropper: CBD, Workplace Screening and the Calm Conversation With Your Employer in 2026

Workplace drug and alcohol policies are a practical reality in many UK safety-critical sectors. This guide explains why a full-spectrum CBD product can produce a THC metabolite, how to read an employer’s policy and occupational health route, and how to keep a calm written record of what you take before any test is requested.

Bottle Price Is Not the Whole Sum: A UK Buyer’s Guide to Cannabinoid Value in CBD Oils
Consumer Guidance

Bottle Price Is Not the Whole Sum: A UK Buyer’s Guide to Cannabinoid Value in CBD Oils

A bottle’s shelf price says little about the cannabinoid it actually delivers. This guide explains how UK shoppers can compare CBD oils by cost per milligram, read batch certificates and avoid apparent bargains that offer poor value.

The Inverted Day: A Clinical Briefing on CBD and Circadian Discipline for UK Shift Workers
Clinical Education

The Inverted Day: A Clinical Briefing on CBD and Circadian Discipline for UK Shift Workers

Night and rotating shifts place unusual demands on sleep, alertness and the commute home. This clinical briefing sets out a cautious framework for UK shift workers considering CBD, with attention to timing, drowsiness, driving risk and occupational-health conversations.

Cool, Dark and Accountable: A 2026 UK Storage Audit for CBD Oils, Capsules and Topicals
Consumer Guidance

Cool, Dark and Accountable: A 2026 UK Storage Audit for CBD Oils, Capsules and Topicals

Storage is often treated as an afterthought in CBD use, yet light, heat, oxygen and humidity can alter a product long before its best-before date. This 2026 UK guide sets out a practical storage audit for oils, capsules and topicals, with clear attention to degradation signs, disposal and the limits of shelf-life claims.

The Mouth as First Contact: A 2026 UK Clinical Briefing on CBD Formats and Oral Health
Clinical Education

The Mouth as First Contact: A 2026 UK Clinical Briefing on CBD Formats and Oral Health

CBD is usually discussed in terms of sleep, anxiety or pain, but the mouth is the first tissue it meets. This briefing considers dry mouth, sugar-laden formats, capsule swallowing and what to tell a UK dentist, without claiming dental benefits for CBD.

The Recovery Rack: CBD, Training Load and Anti-Doping Discipline for UK Athletes in 2026
Clinical Education

The Recovery Rack: CBD, Training Load and Anti-Doping Discipline for UK Athletes in 2026

CBD is often marketed to gym-goers as a recovery shortcut, but the evidence is narrower than the shelf suggests. This clinical-minded guide separates soreness, sleep and stress claims from what UK athletes can reasonably expect, and explains why THC contamination matters under anti-doping rules.

Across the Border With a Bottle: A Measured 2026 Guide to Travelling With CBD
Consumer Guidance

Across the Border With a Bottle: A Measured 2026 Guide to Travelling With CBD

Travelling with CBD from the UK asks more of the label than the bottle. This clinically minded guide sets out how to judge over-the-counter products, prescription cannabis-based medicines, airport security and destination rules before anything goes in the case.

The Winter Medicine Drawer: A Clinical Place for CBD Beside Cold and Flu Remedies
Seasonal Wellness

The Winter Medicine Drawer: A Clinical Place for CBD Beside Cold and Flu Remedies

As UK households restock decongestants, cough medicines and antihistamines for winter 2026, cannabidiol is increasingly appearing on the same shelf. This clinical-minded guide examines where CBD does and does not fit beside cold-and-flu remedies, the interaction questions worth asking, and a practical check-before-you-combine routine.

The Company Cannabinoids Keep: A Clinical Audit of Whole-Plant CBD Claims for UK Shoppers
Clinical Education

The Company Cannabinoids Keep: A Clinical Audit of Whole-Plant CBD Claims for UK Shoppers

Full-spectrum and entourage-effect language is now commonplace on UK CBD shelves, yet the human evidence for synergy remains thin. This clinical audit sets out what batch certificates can verify, what they cannot, and how to decide whether a whole-plant product justifies its premium.

A Four-Week Personal Trial: Recording CBD Dose Without Chasing a Number
Clinical Education

A Four-Week Personal Trial: Recording CBD Dose Without Chasing a Number

There is no universal milligram figure that suits every CBD user, and treating the label as a prescription is a poor substitute for careful observation. This clinician-minded framework sets out a four-week, diary-led approach to finding a tolerable and potentially useful dose, with the GP kept informed and clear stopping rules.